AJP - Regu AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 280: R1657-R1664, 2001;
0363-6119/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, S.-H.
Right arrow Articles by Inenaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, S.-H.
Right arrow Articles by Inenaga, K.
Vol. 280, Issue 6, R1657-R1664, June 2001

Muscarinic modulation of GABAergic transmission to neurons in the rat subfornical organ

Sheng-Hong Xu, Eiko Honda, Kentaro Ono, and Kiyotoshi Inenaga

Department of Physiology, Kyushu Dental College, Kokurakitaku, Kitakyushu 803 - 8580 Japan


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cholinergic actions on subfornical organ (SFO) neurons in rat slice preparations were studied by using whole cell voltage- and current-clamp recordings. In the voltage-clamp recordings, carbachol and muscarine decreased the frequency of GABAergic inhibitory postsynaptic currents (IPSCs) in a dose-dependent manner, with no effect on the amplitudes or the time constants of miniature IPSCs. Meanwhile, carbachol did not influence the amplitude of the outward currents induced by GABA. Furthermore, carbachol and muscarine also elicited inward currents in a TTX-containing solution. From the current-voltage relationship, the reversal potential was estimated to be -7.1 mV. These carbachol-induced responses were antagonized by atropine. In the current-clamp recordings, carbachol depolarized the membrane with increased frequency of action potentials. These observations suggest that acetylcholine suppresses GABA release through muscarinic receptors located on the presynaptic terminals. Acetylcholine also directly affects the postsynaptic membrane through muscarinic receptors, by opening nonselective cation channels. A combination of these presynaptic and postsynaptic actions may enhance activation of SFO neurons by acetylcholine.

inhibitory postsynaptic current; synaptic input; acetylcholine; patch clamp


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

THE SUBFORNICAL ORGAN (SFO), one of the circumventricular organs, plays an important role in cardiovascular regulation, body water balance, and induction of drinking behavior. The SFO receives a cholinergic afferent projection from other brain regions (14). Cholinergic stimulation of the SFO by acetylcholine and carbachol induces water drinking and pressor responses (17, 18). The pressor and drinking responses to acetylcholine and carbachol were blocked by pretreatment with the muscarinic receptor antagonist atropine, whereas nicotinic antagonists had no effect (18). An early in vitro electrophysiological study showed that carbachol increased the firing rates of SFO neurons and that the responses were blocked by atropine (4). Topical application of acetylcholine to the SFO increased the firing rates of these neurons in in vivo studies of rats (26) and cats (7). The effect of acetylcholine was also suppressed by atropine (26). Intracerebroventricular injection of carbachol induced c-Fos expression in the SFO (23). These observations suggest that there are muscarinic acetylcholine receptors in the SFO.

Anatomical (28) and electrophysiological (12, 21) studies indicate that the SFO receives GABAergic synaptic inputs. Several reports suggest that GABA and its analogs influence drinking and cardiovascular responses through the SFO (1, 15, 27). Recent studies have shown the presence of muscarinic subtype receptors in the presynaptic terminals of GABAergic fibers in several regions of the central nervous system (8, 22) and their modulatory action on GABA release (2). The present study examined the effects of acetylcholine action on neurons in the SFO, by the use of brain slice preparations and whole cell patch-clamp recordings.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The techniques used in making slice preparations and whole cell patch-clamp recordings were similar to those reported previously (13, 29). The present study was carried out according to the guidelines of the Animal Experiment Committee, Kyushu Dental College.

Slice preparation. Male Wistar rats weighing 150-250 g were deeply anesthetized with ketamine (250 mg/kg sc) and decapitated after being stunned. Slices of 300-µm thickness were prepared in a cold bathing medium. The brain was cut midway (~45°) between the coronal and horizontal planes (12). The slices were dissected between the hippocampal commissure and corpus callosum. They were preincubated in the bathing medium for at least 1 h before recording. For recording, one slice was submerged in a recording chamber with a volume of 0.2 ml at a constant temperature of 32°C and a perfusion flow rate of 1.6 ml/min. Chemicals were applied to the slices by perfusion from separate storage bottles containing medium to which they had been added.

Solutions and drugs. The normal bathing and perfusion media used in this experiment contained (in mM) 124 NaCl, 5 KCl, 1.24 KH2PO, 1.3 Mg2SO4, 2.1 CaCl2, 26 NaHCO3, and 10 glucose at pH 7.4. All of the bathing and perfusion media used in this study were saturated with a mixture of 95% O2 and 5% CO2. Drugs were purchased from the following pharmaceutical companies: atropine sulfate, (-)-bicuculline methiodide, carbamylcholine chloride (carbachol), hexamethonium chloride, kynurenic acid, (+)-muscarine chloride, and tetrodotoxin (TTX) from Sigma (St. Louis, MO), 6-cyano-7-nitroqunoxaline-2,3-dione (CNQX) and 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) from Research Biochemicals International (Natick, MA), and gamma -aminobutyric acid (GABA) from Merck.

Recordings and data analysis. Whole cell voltage- and current-clamp recordings were obtained as previously described (11). Patch pipettes were double pulled (P-97, Sutter Instrument) from thin-wall borosilicate glass (OD 1.5 mm, ID 1.12 mm) and were coated, except at the tip, with nail enamel to reduce the electrode capacitance. The pipette solution contained (in mM) 130 K gluconate, 10 KCl, 1 MgCl2, 1 CaCl2, 5 EGTA, 10 HEPES, and 4 Na2ATP (pH 7.2, adjusted with 1 N KOH). Open resistances of the patch pipette ranged between 10 and 14 MOmega . Currents were recorded with whole cell clamp amplifiers (AXOPATCH 200A, Axon Instruments), low-pass filtered at 1-2 kHz, displayed on an oscilloscope (VC-10, Nihon Kohden) and a chart recorder (Nihon Kohden, RM-6100), and stored on a videotape (VR-10B, Instrutech) for further analysis. Series resistance in the whole cell configuration was less than 50 MOmega and compensated. Membrane potentials were clamped to -81 mV for excitatory postsynaptic currents (EPSCs) and to -51 or -56 mV for inhibitory PSCs (IPSCs). To get a current-voltage relationship, the negative going ramp commands of 100 mV were applied at a rate of 50 mV/s. Potential values were corrected for the junction potential (11 mV) in analysis. Data were analyzed off-line by using pCLAMP and AxoGraph (Axon Instruments) and an analog-digital converter (MacLab/8, ADI). To analyze synaptic currents quantitatively, the alternating current components were used for analysis with two software packages (AxoGraph v.3 and MacLab v.3.5.1 Spike Histogram). The analysis of synaptic currents was done at a time point when the responses were maximal. Use of an event-detection threshold, which was set at the beginning of the analysis and thereafter held constant, allowed events to be detected with recording segments of 120 s in duration. The Kolmogorov-Smirnov test was used to determine if two distributions were different, with a criterion of P < 0.05. The Student's paired t-test was performed for analytical comparison. EC50 and IC50 values were obtained by the Prism curve-fitting program (GraphPad Software) based on Michaelis-Menten's equation. The numerical data are given as means ± SE, and n represents the number of neurons tested.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Glutamatergic and GABAergic synaptic currents. The effects of glutamate and GABA receptor antagonists on the postsynaptic currents were studied. The spontaneous EPSCs (sEPSCs) were almost completely suppressed by the glutamate receptor antagonist kynurenic acid (1 mM, n = 6, 0.92 ± 0.19 to 0.22 ± 0.05 Hz, 76% decrease) and the non-N-methyl-D-aspartate receptor antagonist CNQX (3 µM, n = 8, 0.91 ± 0.12 to 0.20 ± 0.07 Hz, 78% decrease) (29). The sIPSCs were also almost completely suppressed by the GABA receptor antagonist picrotoxin (50 µM, n = 7, 10.8 ± 3.5 to 0.13 ± 0.07 Hz, 98% decrease) and the GABAA receptor antagonist bicuculline (10 µM, n = 6, 6.7 ± 2.4 to 0.33 ± 0.22 Hz, 95% decrease). These results suggest that glutamate and GABA influenced SFO neurons as excitatory and inhibitory neurotransmitters, respectively, under our experimental conditions.

Carbachol-induced suppression of spontaneous and miniature inhibitory postsynaptic inputs. The effects of carbachol on sIPSCs were tested. Of 87 neurons, sIPSCs were decreased in 80 neurons by application of carbachol at 10 µM but increased in one neuron (data not shown). Six neurons showed no response. The effects of carbachol at 10 µM on miniature IPSCs (mIPSCs) remained in nine of 10 neurons in the presence of 0.3 µM TTX (Fig. 1). The mean frequency of the mIPSCs was decreased by carbachol at 10 µM from 5.73 ± 1.83 to 2.94 ± 1.64 Hz (49% decrease). Changes of amplitudes and time constants were further analyzed for the nine neurons. In all nine neurons, carbachol changed neither the amplitudes (Fig. 1C) nor the time constants (Fig. 2), implying that the action of carbachol occurs in the presynaptic terminals.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Carbachol suppresses the frequency of miniature inhibitory postsynaptic currents (mIPSCs) in a subfornical organ (SFO) neuron. A: a representative example of inhibition of mIPSCs by carbachol (CCh) at 10 µM. The perfusion medium contained 0.3 µM TTX. Top, a current trace; bottom, ratemeter record of IPSC frequency. B: expanded current records in control (a), during application of CCh (b), and in washout (c) in A. C: cumulative probability plots of mIPSCs amplitude (a) and interevent intervals (b) in control and during application of CCh. The mean amplitude and number of mIPSCs were 16.8 ± 0.3 pA and 267 events in control (a) and 16.6 ± 0.6 pA and 94 events in the presence of CCh during a 120-s recording period. Note that CCh produces no significant change in the distribution of mIPSCs amplitudes but that the distribution of interevent intervals is shifted toward longer intervals. The holding potential was -51 mV.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2.   No effects of CCh on time constant of mIPSCs. At left, a current trace of mIPSC. The dotted line shows that the falling phase of the mIPSC fits a single exponential function. We estimated the time constant by curve-fitting procedure with the software of AxoGraph. The curve-fitting analysis was done for 20 events of mIPSCs in the control and in the presence of CCh in a neuron in Fig. 1. At right, the averaged time constants were 12.8 ± 0.6 ms in the control and 13.4 ± 0.9 ms in the presence of carbachol at 10 µM. Note that CCh produces no significant change in the time constants of mIPSCs.

The decrement ratio of sIPSC frequency by carbachol was concentration dependent (Fig. 3). The EC50 value for the carbachol effects was 7.2 µM. The effects of the muscarinic receptor agonist muscarine on the IPSCs were also investigated (Fig. 4). Application of muscarine induced a similar inhibitory response to that of carbachol. The EC50 value for the muscarine effects was 25 µM. These values of EC50 were similar to 29.5 µM for carbachol, the value of which was obtained from the cortex (6), and 15 µM for muscarine, the value of which was obtained from the septum (9) in studies using slice preparations.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Dose-dependent inhibition of spontaneous IPSCs (sIPSCs) in frequency by CCh. A: change of frequency of sIPSCs in ratemeter records from 2 SFO neurons, in application of CCh at 0.1-100 µM. The ratemeter record at 0.1 µM was obtained from an SFO neuron. Other ratemeter records (1-100 µM) were obtained from another neuron. Application of CCh was performed at the times indicated by the horizontal bars. The holding potential was -56 mV. B: the dose-response relationship for CCh- and muscarine (Mus)-induced inhibition of the frequency. Changes of mean frequency (Freq) and amplitude (Amp) during CCh application to those in the control are expressed as percentages. Note that CCh and muscarine produce no significant changes in the distribution of sIPSCs amplitudes. Each plot shows a mean value obtained from 9-12 SFO neurons.



View larger version (39K):
[in this window]
[in a new window]
 
Fig. 4.   Muscarine suppresses frequency of sIPSCs in an SFO neuron. A: a representative example of inhibition of sIPSCs by muscarine at 100 µM. Top, a current trace; bottom, a ratemeter record of IPSC frequency. B: expanded current records in control (a), during application of muscarine (b), and in washout (c) in A. C: cumulative probability plots of sIPSCs amplitude (a) and interevent intervals (b) in control and during application of muscarine. The mean amplitude and number of sIPSCs were 15.9 ± 0.2 pA and 619 events in control (a) and 16.3 ± 0.2 pA and 392 events in the presence of CCh during a 120-s recording period. Note that muscarine produces no significant change in the distribution of sIPSCs amplitudes but that the distribution of interevent intervals is shifted toward longer intervals. The holding potential was -56 mV.

Effects of the muscarinic receptor antagonist atropine on carbachol-induced inhibitory responses. To clarify further the type of receptors involved in the carbachol response, we investigated the effects of the muscarinic receptor antagonist atropine on carbachol-induced inhibitory responses of sIPSCs (Fig. 5). As shown in Fig. 5B, atropine antagonized the inhibitory responses induced by carbachol at 10 µM in a dose-dependent manner. The effects of the nicotinic receptor antagonist hexamethonium on carbachol-induced responses of sIPSCs were also investigated. Hexamethonium at 100 µM did not influence the inhibitory responses induced by carbachol at 10 µM (n = 6, data not shown).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 5.   Selective response of CCh to IPSCs and effects of the muscarinic receptor antagonist atropine on CCh-induced suppression of IPSC frequency. A: atropine at 1 µM antagonized the CCh (10 µM)-induced suppression of sIPSC frequency in an SFO neuron. Top, current traces for control (a), in application of atropine at 1 µM (b), and washout (c). Middle, a ratemeter record of IPSC frequency. Bottom, a ratemeter record of EPSC frequency. In a and c, CCh reduced the frequency of sIPSCs but not spontaneous excitatory postsynaptic currents (sEPSCs). B: the dose-response relationship for atropine on the CCh-induced responses. IC50 was estimated as 75 nM. n, number of neurons. The holding potentials were -51 mV.

Carbachol does not affect GABA-induced outward currents. To study further the presynaptic action of carbachol in the SFO, we examined its effects on GABA-induced outward currents. Application of GABA at 1 mM induced outward currents (n = 5, 95.4 ± 15.1 pA) at the holding potential of -51 mV. The GABA-induced outward currents were not influenced by carbachol at 10 µM in any of the five neurons tested (97.0 ± 2.7% vs. control, Fig. 6). The perfusion medium contained 0.3 µM TTX.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   CCh does not affect GABA induced outward current. A, B, and C: current traces for control, application of CCh at 10 µM, and washout. GABA at 1 mM induced outward currents. The GABA-induced outward current was not influenced by the CCh application.

Selective suppression of carbachol to sIPSCs. The effects of carbachol on sEPSCs were investigated. Figure 5Aa shows that carbachol at 10 µM did not influence EPSCs although it did reduce the frequency of sIPSCs in the same SFO neuron. In 11 of 13 neurons tested, carbachol at 10-100 µM had no effect on sEPSCs. Because carbachol at 10 µM decreased the frequency of sIPSCs in 80 of 87 neurons, these findings suggest that carbachol selectively influences IPSCs.

Carbachol induced inward currents. Application of carbachol induced inward currents at the holding potentials of -51 mV (Fig. 7A). The mean carbachol-induced inward currents were 29.9 ± 3.4 pA in 41 of 69 neurons at 10 µM carbachol and 36.5 ± 7.8 pA in 14 of 32 neurons at 100 µM. Application of muscarine at 100 µM also induced inward currents at the holding potential of -51 mV. Inward currents were observed in seven of 12 neurons tested. The mean muscarine-induced inward current was 50.7 ± 19.3 pA. The carbachol-induced responses remained in TTX (0.3 µM)-containing perfusion medium. The mean carbachol-induced inward currents were 37.5 ± 1.0 pA in six of 23 neurons at 10 µM carbachol and 44.0 ± 7.2 pA in 20 of 38 neurons at 100 µM in the presence of TTX. The responses were almost completely blocked by atropine at 1 µM (n = 6, 97% decrease) (Fig. 7A). We examined the effects of the M3/M1 muscarinic receptor antagonist 4-DAMP on the carbachol (10 µM)-induced currents. The drug at 0.1 µM almost completely suppressed the carbachol-induced currents (n = 6, 95% decrease, data not shown).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 7.   CCh-induced inward current and membrane depolarization. A: blockade of the CCh-induced inward current by atropine. CCh at 10 µM induced an inward current (a), and atropine at 1 µM completely suppressed the CCh-induced inward current (b). c shows the recovery. a, b, and c were obtained from an SFO neuron. The holding potential was -51 mV. B: membrane conductance change in a CCh-induced inward current. Top, an inward current by CCh at 100 µM in an SFO neuron. Ramp commands were applied in dots. Bottom, a current-voltage relationship with the ramp stimulation in (1) and in (2) at top. The CCh application increased membrane conductance. A line (2) - (1) shows a net current induced by CCh. A reversal potential was estimated to be -3.5 mV. The perfusion medium contained 0.3 µM TTX. The holding potential was -51 mV.

To understand the mechanisms involved in the responses, we applied ramp stimulation to SFO neurons in the presence and absence of carbachol. Ten SFO neurons that were sensitive to carbachol were analyzed. In seven of the 10 neurons, membrane conductance was increased with a reversal potential in the presence of carbachol, as shown in Fig. 7B. The mean reversal potential was estimated to be -7.1 ± 5.1 mV. In the three remaining neurons, no marked change of membrane conductance was observed within the range tested. These results suggest that inward currents are induced through muscarinic receptors in the postsynaptic membrane of SFO neurons by activation of nonselective cation channels.

Effects of carbachol on membrane potentials in the current-clamp experiment. In this experiment, the effects of carbachol at 10 and 100 µM on 16 SFO neurons were investigated. Carbachol depolarized the membrane 12.6 ± 4.8 mV at 10 µM (n = 3) and 15.0 ± 3.3 mV at 100 µM (n = 13) in all neurons tested. The mean value of the resting membrane potentials was -61.6 ± 0.6 mV. In seven of 13 neurons, 100 µM carbachol also increased frequency of action potentials. The carbachol-induced depolarization still remained in the TTX-containing medium (Fig. 8, A and B). Carbachol at 100 µM depolarized the membrane 17.0 ± 4.8 mV in all neurons tested (n = 9). The depolarization increased in a dose-related manner (Fig. 8, B and C). The responses were reversible and repeatable (n = 3, Fig. 8B). These results suggest that carbachol directly depolarizes the membrane of SFO neurons.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of CCh on membrane potential. CCh depolarized the membrane of SFO neurons in current clamp mode in A and B. CCh was applied at the time indicated by the horizontal bar. In A, CCh induced increase of action potentials with membrane depolarization in an SFO neuron. The action potentials were truncated. The CCh-induced depolarization still remained in the presence of 0.3 µM TTX. The second application of CCh was done 20 min after the first. The resting membrane potential was -55 mV. B: CCh-induced depolarization is repeatable and increased with the concentration in another SFO neuron. The resting membrane potential was -62 mV. The perfusion medium contained 0.3 µM TTX. C: CCh-induced depolarization is increased in a dose-dependent manner. Each line in C was obtained from 4 SFO neurons in which the responses at >2 different doses were observed in the presence of 0.3 µM TTX.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Suppression of GABA release by activation of muscarinic receptors. The present observation that IPSCs were almost completely suppressed by the GABA receptor antagonists implies that GABA is a main inhibitory neurotransmitter in the SFO. This is consistent with our previous studies of intracellular recordings (12). Recent studies have demonstrated the presence of muscarinic subtype receptors in the presynaptic terminals of GABAergic fibers in several regions of the central nervous system (8, 22) and their modulatory action on GABA release (2). Baba et al. (2) showed that muscarinic receptor stimulation facilitates GABA release in the rat spinal dorsal horn. Several lines of evidence in the present study demonstrate that acetylcholine modulates neuronal activity in the nerve terminals through muscarinic receptors and inhibits GABA release. Carbachol decreased the frequency of IPSCs without changes of amplitude and time constants. Carbachol did not influence GABA-induced outward currents. These responses still remained in the presence of TTX, implying that the action is not due to action potential-dependent synaptic events. The muscarinic receptor antagonist atropine suppressed the carbachol-induced inhibition of IPSCs, whereas the nicotinic receptor antagonist hexamethonium did not influence it.

Carbachol actions were observed only in IPSCs, not in EPSCs. Our recent study demonstrated that EPSCs are due to glutamatergic synaptic inputs (29). Several studies of synaptic transmissions with whole cell clamp recordings from neurons in the reticular formation (3), the hippocampus (25), and the magnocellular basal forebrain (25) demonstrated that glutamatergic excitatory synaptic inputs are suppressed presynaptically by acetylcholine. Unlike in the other regions of the brain, acetylcholine may not suppress glutamate release but may selectively suppress GABA release in the SFO of rats.

In this study, both GABAergic mIPSCs and whole cell GABA currents were examined. Although the mIPSCs were often of amplitudes >30 pA, the largest peak currents resulting from exogenous application of GABA were only in the order of 140 pA (the mean peak current was 95.4 pA). As suggested by various studies (for example, Ref. 19), it is likely that the desensitization of GABA at high concentrations is very rapid so that it reduces the peak current. In the present study, 1 mM GABA was applied to the bath. The concentration of GABA in the bath gradually changed, and it took 30 s to reach the maximal concentration. As shown in Fig. 6, the GABA-induced outward currents were reduced before the concentration reached the maximum, suggesting that the SFO neurons were also rapidly desensitized by GABA.

Carbachol induced inward currents. Carbachol induced inward currents in half the SFO neurons. In most SFO neurons showing carbachol-induced inward currents, an increased membrane conductance was observed and the mean reversal potential was -7.1 mV. A study in rat septal nucleus neurons in slice preparations (9) found that muscarine induces inward currents with increased membrane conductance and that the mean reversal potential is -17 mV, suggesting that the currents are mediated through opening of nonselective cation channels. Although the reversal potential in the study is more negatively shifted than that in the present study, these findings are almost consistent with ours. Thus the present results suggest the involvement of nonselective cation channels in the carbachol-induced responses. However, the net currents induced by carbachol in this study were not always linear, as shown in Fig. 7. This may imply partial involvement of the other ion channels except nonselective cation channels in the carbachol responses. A study in pyramidal neurons dissociated from the rat cerebral cortex (20) revealed that acetylcholine induced an inward current with a membrane conductance decrease due to the suppression of the voltage- and time-dependent K+ current (M current). Shen and North (24) noted that muscarine elicited the inward current through both opening of voltage-independent cation channels and closing of potassium channels in rat locus coeruleus neurons.

Hasuo et al. (9) demonstrated that muscarine activates a nonselective cation channel through an M3 receptor subtype in dorsolateral neurons of rats. The present study showed that the M3/M1 receptor antagonist 4-DAMP almost completely suppressed the carbachol-induced currents. Although this suggests the involvement of the M3 receptor subtype in the action of the carbachol-induced inward currents of SFO neurons, further systematic pharmacological experiments are necessary to confirm this hypothesis.

Function of acetylcholine. GABA-gated ion channels in the SFO have an equilibrium potential more negative than the resting membrane potential (12). Thus the GABAergic synaptic inputs produce inhibitory responses in SFO neurons. Our previous findings (12) by conventional intracellular recordings demonstrated that application of the GABAA receptor antagonists bicuculline and picrotoxin depolarize membranes and suggested that GABA neurones tonically inhibit activity of SFO neurons. This study demonstrates that carbachol suppresses GABA release from the presynaptic terminals through the muscarinic receptors. This implies disinhibition of SFO neurons by carbachol. Our present study also demonstrates induction of inward currents and membrane depolarization through the muscarinic receptors by carbachol, indicating a direct postsynaptic action of acetylcholine on SFO neurons. Together, the combination of presynaptic and postsynaptic actions by acetylcholine may facilitate neuronal activity of SFO neurons.

Perspectives

The SFO is a brain region that is innervated by a cholinergic pathway that mediates information on body fluid balance. This study demonstrated modulatory action of the cholinergic inputs on activity of SFO neurons. The origin of the cholinergic fibers still remains to be clarified. Lind et al. (16) showed that horseradish peroxidase injection into the SFO labeled neurons in the medial septum. A histochemical study (10) detected expression and immunoreactivity of choline acetyltransferase and vesicular acetylcholine transporter in neurons of the same regions. These findings suggest that cholinergic fibers in the SFO originate from the medial septum.

To demonstrate pharmacologically the subtypes of muscarinic receptors, several antagonists are available (see Ref. 5 for review). In this study, we used a muscarinic receptor antagonist, 4-DAMP, only, and the results suggest M3 receptor involvement in the postsynaptic responses. Further experiments are necessary to identify subtypes of muscarinic receptors involved in presynaptic and postsynaptic responses.


    ACKNOWLEDGEMENTS

This work was supported by Grants-in-Aid for Scientific Research 09670076 and 11671848 from the Ministry of Education, Science, Sports and Culture, Japan (to K. Inenaga). S.-H. Xu was supported by a fellowship from the Japan Society for the Promotion of Science.


    FOOTNOTES

Present address of S.-H. Xu: Institute of Neurology, Anhui College of T.C.M., Meishan Road 27, Hefei 230031, Peoples' Republic of China

Address for reprint requests and other correspondence: K. Inenaga, Dept. of Physiology, Kyushu Dental College, Kokurakitaku, Kitakyushu 803-8580, Japan (E-mail: ine{at}kyu-dent.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 20 March 2000; accepted in final form 6 February 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abe, M, Tokunaga T, Yamada K, and Furukawa T. Gamma-aminobutyric acid and taurine antagonize the central effects of angiotensin II and renin on the intake of water and salt, and on blood pressure in rats. Neuropharmacology 27: 309-318, 1988[ISI][Medline].

2.   Baba, H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, and Yoshimura M. Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol (Lond) 508: 83-93, 1998[Abstract/Free Full Text].

3.   Bellingham, MC, and Berger AJ. Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors. J Neurophysiol 76: 3758-3770, 1996[Abstract/Free Full Text].

4.   Buranarugsa, P, and Hubbard JI. The neuronal organization of the rat subfornical organ in vitro and a test of the osmo- and morphine-receptor hypotheses. J Physiol (Lond) 291: 101-116, 1979[Abstract/Free Full Text].

5.   Caulfield, MP, and Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279-290, 1998[Abstract/Free Full Text].

6.   Chessell, IP, and Humphrey PP. Nicotinic and muscarinic receptor-evoked depolarizations recorded from a novel cortical brain slice preparation. Neuropharmacology 34: 1289-1296, 1995[ISI][Medline].

7.   Felix, D. Peptide and acetylcholine action on neurones of the cat subfornical organ. Naunyn Schmiedebergs Arch Pharmacol 292: 15-20, 1976[ISI][Medline].

8.   Hajos, N, Papp EC, Acsady L, Levey AI, and Freund TF. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 82: 355-376, 1998[ISI][Medline].

9.   Hasuo, H, Akasu T, and Gallagher JP. Muscarine activates a nonselective cation current through a M3 muscarinic receptor subtype in rat dorsolateral septal nucleus neurons. J Neurophysiol 76: 2221-2230, 1996[Abstract/Free Full Text].

10.   Ichikawa, T, Ajiki K, Matsuura J, and Misawa H. Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry. J Chem Neuroanat 13: 23-39, 1997[ISI][Medline].

11.   Inenaga, K, Cui L-N, Nagatomo T, Honda E, Ueta Y, and Yamashita H. Osmotic modulation in glutamatergic excitatory synaptic inputs to neurons in the supraoptic nucleus of rat hypothalamus in vitro. J Neuroendocrinol 9: 63-68, 1997[ISI][Medline].

12.   Inenaga, K, Nagatomo T, Honda E, Ueta Y, and Yamashita H. GABAergic inhibitory inputs to subfornical organ neurons in rat slice preparations. Brain Res 705: 85-90, 1995[ISI][Medline].

13.   Inenaga, K, Nagatomo T, Kannan H, and Yamashita H. Inward sodium current involvement in regenerative bursting activity of rat magnocellular supraoptic neurones in vitro. J Physiol (Lond) 465: 289-301, 1993[Abstract/Free Full Text].

14.   Johnson, AK, and Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 7: 678-686, 1993[Abstract].

15.   Jones, DL, and Mogenson GJ. Central injections of spiperone and GABA: attenuation of angiotensin II stimulated thirst. Can J Physiol Pharmacol 60: 720-726, 1982[ISI][Medline].

16.   Lind, RW, van Hoesen GW, and Johnson AK. An HRP study of the connections of the subfornical organ of the rat. J Comp Neurol 210: 265-277, 1982[ISI][Medline].

17.   Mangiapane, ML, and Simpson JB. Drinking and pressor responses after acetylcholine injection into subfornical organ. Am J Physiol Regulatory Integrative Comp Physiol 244: R508-R513, 1983.

18.   Mangiapane, ML, and Simpson JB. Pharmacologic independence of subfornical organ receptors mediating drinking. Brain Res 178: 507-517, 1979[ISI][Medline].

19.   Nabekura, J, Noguchi K, Witt MR, Nielsen M, and Akaike N. Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid. J Biol Chem 273: 11056-11061, 1998[Abstract/Free Full Text].

20.   Nishikawa, M, Munakata M, and Akaike N. Muscarinic acetylcholine response in pyramidal neurones of rat cerebral cortex. Br J Pharmacol 112: 1160-1166, 1994[ISI][Medline].

21.   Osaka, T, Yamashita H, and Koizumi K. Inhibitory inputs to the subfornical organ from the AV3V: involvement of GABA. Brain Res Bull 29: 581-587, 1992[ISI][Medline].

22.   Plummer, KL, Manning KA, Levey AI, Rees HD, and Uhlrich DJ. Muscarinic receptor subtypes in the lateral geniculate nucleus: a light and electron microscopic analysis. J Comp Neurol 404: 408-425, 1999[ISI][Medline].

23.   Rowland, NE, Li B-H, Rozelle AK, and Smith GC. Comparison of Fos-like immunoreactivity induced in rat brain by central injection of angiotensin II and carbachol. Am J Physiol Regulatory Integrative Comp Physiol 267: R792-R798, 1994[Abstract/Free Full Text].

24.   Shen, KZ, and North RA. Muscarine increases cation conductance and decreases potassium conductance in rat locus coeruleus neurones. J Physiol (Lond) 455: 471-485, 1992[Abstract/Free Full Text].

25.   Sim, JA, and Griffith WH. Muscarinic inhibition of glutamatergic transmissions onto rat magnocellular basal forebrain neurons in a thin-slice preparation. Eur J Neurosci 8: 880-891, 1996[ISI][Medline].

26.   Tanaka, J, Kaba H, Saito H, and Seto K. Subfornical organ neurons with efferent projections to the hypothalamic paraventricular nucleus: an electrophysiological study in the rat. Brain Res 346: 151-154, 1985[ISI][Medline].

27.   Unger, T, Bles F, Ganten D, Lang RE, Rettig R, and Schwab NA. GABAergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin. Eur J Pharmacol 90: 1-9, 1983[ISI][Medline].

28.   Weindl, A, Bufler J, Winkler B, Arzberger T, and Hatt H. Neurotransmitters and receptors in the subfornical organ. Immunohistochemical and electrophysiological evidence. In: Progress in Brain Research, edited by Ermisch A, Landgraf R, and Rühle H-J.. Amsterdam: Elsevier Science, 1992, p. 261-269.

29.   Xu, SH, Inenaga K, Honda E, and Yamashita H. Glutamatergic synaptic inputs activate neurons in the subfornical organ through non-NMDA receptors. J Auton Nerv Syst 78: 177-180, 2000[ISI][Medline].


Am J Physiol Regul Integr Comp Physiol 280(6):R1657-R1664
0363-6119/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Honda, K. Ono, S. Kataoka, and K. Inenaga
Activation of subfornical organ neurons in rats through pre- and postsynaptic {alpha}-adrenoceptors
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1646 - R1653.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
N. Sato, K. Ono, E. Honda, K. Haga, M. Yokota, and K. Inenaga
Pilocarpine-induced Salivation and Thirst in Conscious Rats
J. Dent. Res., January 1, 2006; 85(1): 64 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. J. Michel, J. M. Robillard, and L.-E. Trudeau
Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors
J. Physiol., April 15, 2004; 556(2): 429 - 445.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, S.-H.
Right arrow Articles by Inenaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, S.-H.
Right arrow Articles by Inenaga, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online